BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 17140846)

  • 1. Transcallosal inhibition in amyotrophic lateral sclerosis.
    Wittstock M; Wolters A; Benecke R
    Clin Neurophysiol; 2007 Feb; 118(2):301-7. PubMed ID: 17140846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirror movements and ipsilateral motor evoked potentials in ALS.
    Krampfl K; Mohammadi B; Komissarow L; Dengler R; Bufler J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):154-63. PubMed ID: 15512904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis.
    Zanette G; Tamburin S; Manganotti P; Refatti N; Forgione A; Rizzuto N
    J Neurol; 2002 Dec; 249(12):1723-8. PubMed ID: 12529797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation.
    Iwata NK; Aoki S; Okabe S; Arai N; Terao Y; Kwak S; Abe O; Kanazawa I; Tsuji S; Ugawa Y
    Neurology; 2008 Feb; 70(7):528-32. PubMed ID: 18268244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis.
    Sach M; Winkler G; Glauche V; Liepert J; Heimbach B; Koch MA; Büchel C; Weiller C
    Brain; 2004 Feb; 127(Pt 2):340-50. PubMed ID: 14607785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of central motor abnormalities in amyotrophic lateral sclerosis.
    Mills KR
    Brain; 2003 Nov; 126(Pt 11):2558-66. PubMed ID: 12937082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired interhemispheric inhibition in amyotrophic lateral sclerosis.
    Karandreas N; Papadopoulou M; Kokotis P; Papapostolou A; Tsivgoulis G; Zambelis T
    Amyotroph Lateral Scler; 2007 Apr; 8(2):112-8. PubMed ID: 17453640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirror movements in amyotrophic lateral sclerosis.
    Wittstock M; Meister S; Walter U; Benecke R; Wolters A
    Amyotroph Lateral Scler; 2011 Nov; 12(6):393-7. PubMed ID: 21554031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
    Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
    Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurophysiological analysis of interhemispheric motor tracts in neurodegenerative diseases].
    Wittstock M
    Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S42-4. PubMed ID: 19685392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, blind study of the triple stimulation technique in the diagnosis of ALS.
    Kleine BU; Schelhaas HJ; van Elswijk G; de Rijk MC; Stegeman DF; Zwarts MJ
    Amyotroph Lateral Scler; 2010; 11(1-2):67-75. PubMed ID: 19714538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor evoked potentials (MEPs): evaluation of the different types of responses in amyotrophic lateral sclerosis and primary lateral sclerosis.
    Salerno A; Carlander B; Camu W; Georgesco M
    Electromyogr Clin Neurophysiol; 1996 Sep; 36(6):361-8. PubMed ID: 8891476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic lateral sclerosis and primary lateral sclerosis: The role of diffusion tensor imaging and other advanced MR-based techniques as objective upper motor neuron markers.
    Wang S; Melhem ER
    Ann N Y Acad Sci; 2005 Dec; 1064():61-77. PubMed ID: 16394148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of cortical and spinal dysfunctions over time in amyotrophic lateral sclerosis.
    Attarian S; Vedel JP; Pouget J; Schmied A
    Muscle Nerve; 2008 Mar; 37(3):364-75. PubMed ID: 18080998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the mechanisms that underlie cortical hyperexcitability in amyotrophic lateral sclerosis.
    Vucic S; Cheah BC; Kiernan MC
    Exp Neurol; 2009 Nov; 220(1):177-82. PubMed ID: 19716820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis.
    Vucic S; Kiernan MC
    Clin Neurophysiol; 2008 May; 119(5):1088-96. PubMed ID: 18313980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy.
    Pachatz C; Terracciano C; Desiato MT; Orlacchio A; Mori F; Rocchi C; Bernardi G; Massa R
    Clin Neurophysiol; 2007 Feb; 118(2):262-8. PubMed ID: 17137837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.